The transdermal drug delivery system market was valued at US$5.914 billion in 2019 and is expected to grow at a CAGR of 4.71% over the forecast period to reach a total market size of US$8.162 billion by 2026. The developing patient inclination for the torment-free prescription organization has brought about an impressive expansion in the reception pace of medication overseeing adhesive skin patches, as would be considered normal to offer the market solid development potential.